Department of Vascular Surgery, University Hospital Aachen, Aachen, Germany.
Department of Vascular Surgery, Clinical Center of Rhein-Maas, Würselen, Germany.
Vasa. 2021 Jan;50(1):45-51. doi: 10.1024/0301-1526/a000917. Epub 2020 Oct 28.
: The aim of this study is to evaluate long term outcome in patients treated for benign superior vena cava (SVC) syndrome by endovascular techniques. : Between 2015 and 2018, 62 patients suffering from central venous obstruction of benign etiology underwent balloon angioplasty with stent placement for venous obstruction in our department. Patency was assessed clinically, using duplex ultrasound in all patients or with CT-phlebography in selected cases. : Median age was 60 years (23-83), forty-one patients (66%) had central venous devices. Swelling of the arm and face were the main symptoms (71%). During the median follow up of 22 months (9-38), cumulative primary patency was 71% after venous stenting. The cumulative assisted primary and the secondary patency were 85% and 92%, respectively. : Recanalization and stenting of central vein obstruction has turned out to be the technique of reference and provides satisfactory mid-term patency rates. After adjusting for the risk factors, presence of AV-fistula remained a significant risk factor for recurrent stenosis or loss of patency after intervention.
本研究旨在评估采用血管内技术治疗良性上腔静脉（SVC）综合征患者的长期预后。
在 2015 年至 2018 年间，我们科室对 62 名因良性病因导致中心静脉阻塞的患者进行了球囊血管成形术和支架置入术治疗静脉阻塞。所有患者均采用双功能超声进行通畅性评估，在选择性病例中采用 CT 静脉造影进行评估。
患者中位年龄为 60 岁（23-83 岁），41 名患者（66%）有中心静脉装置。手臂和面部肿胀是主要症状（71%）。在中位随访 22 个月（9-38 个月）期间，静脉支架置入术后的累积一期通畅率为 71%。累积辅助一期和二期通畅率分别为 85%和 92%。
复通和支架置入术已成为治疗中心静脉阻塞的参考技术，提供了令人满意的中期通畅率。在调整了风险因素后，AV 瘘的存在仍然是介入治疗后再狭窄或失去通畅的显著风险因素。
